Page not found

Search results

  1. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    12/05/2023 A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug ... for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.   The drug is an allosteric ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  2. Rethinking drug efficacy: research aims to improve drug development

    ... build on this work by applying the approach to different therapeutic areas and exploring the implications for drug formulation and ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... altering the current drug development procedures, the technology has potential to facilitate the creation of entirely novel drug ...

    sommers - 03/11/2024 - 8:54am

  3. Oral administration of levocarnitine for treating Sjögren's Syndrome-associated dry eye

    ... have identified levocarnitine as a novel potential therapeutic for treating this condition.   Addressed Need ... provide only temporary relief from symptoms. The proposed technology of oral levocarnitine administration offers a novel approach for ...

    cttc_admin - 02/15/2024 - 1:31pm

  4. Anti-inflammatory microparticles for sustained ocular drug delivery

    ... cargos in the eye for at least 6 weeks while also playing a therapeutic role in reducing inflammation. Addressed Need ... gold standard poly(lactic-co-glycolic acid) (PLGA). Technology Description To overcome these challenges, Vanderbilt ...

    cttc_admin - 02/01/2024 - 12:21pm

  5. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... that activating immune cells with this method may improve therapeutic efficacy and reduce manufacturing expenses.   ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  6. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... cover specific predictive biomarkers that cover a range of therapeutic classes.   Emanuel Petricoin, Ph.D., Chair of Theralink’s ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  7. Current Request for Proposals

    ... Bifunctional Small Molecule Compound Technology that Modulates Protein-Protein Interactions ... Novel Targets Involved in Ferroptosis for Therapeutic Development in Oncology ...

    cttc_admin - 12/13/2023 - 4:47pm

  8. Company co-founded by Vanderbilt professor receives distinguished FDA breakthrough device designation for minimally invasive surgical tool

    ...  that could open the door for new diagnostic and therapeutic applications of flexible endoscopy. The designation given to  ... conditions. EndoTheia’s device leverages foundational technology that was originally invented at Vanderbilt and the University of ...

    sommers - 01/11/2023 - 10:03am

  9. CTTC Announces the Awardees of the 2023 Master Innovator Recognition Program

    09/01/2023 Each year, the Center for Technology Transfer and Commercialization (CTTC) recognizes excellence in ... personalized medicine, drug discovery, and the diagnosis and treatment of diseases such as cancer by developing innovative imaging ...

    sommers - 09/12/2023 - 10:19am

  10. Philip Swaney

    ... Lab led by Dr. Robert Webster III. He also spent time as a technology transfer intern at CTTC. In his graduate work, Phil developed a ... and tools in collaboration with expert surgeons for the treatment of diseases in the lung and brain. Philip received his B.S. in ...

    mullerg - 03/08/2024 - 9:53am